Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 18 recruiting now full pipeline

Menopause: full-pipeline trial registry

18 of 55 indexed Menopause trials are currently recruiting.

Corpus placement: #254 of 28,707 conditions by registered trial count.

55 US clinical trials · 18 currently recruiting · #254 of 28,707 conditions by registered trial count

Menopause: 55 US clinical trials tracked, 18 recruiting.

Menopause is the subject of 55 registered US clinical trials on ClinicalTrials.gov, 18 of them currently open to new participants. 12 are in Phase 3-4 (later-stage) and 17 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 6 of these trials.

Enrollment posture brief

Registry condition menopause

OPEN 18 | RECR 33% | LATE 12 | EARLY 17 | RANK #254 | SPON 6

Nearest open-share peer: Non-alcoholic Fatty Liver Disease (33% recruiting · 58 trials)

Colorectal Neoplasms41.8%Down Syndrome38.2%Menopause (this)33%Constipation27.3%Brain and Central Nervous Sy1.8%
Open-enrollment share among volume-matched conditions near Menopause

Menopause lists 18 open slots (33% of 55 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Menopause on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Menopause is recruiting below its size-band peers.

    18 of 55 indexed trials (32.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Menopause trials is spread across many organizations.

    University of Colorado, Denver accounts for 6 of 55 trials (10.9%). 38 distinct sponsors appear on at least one study for this condition label.

  3. Most Menopause trials plan to enrol fewer than 100 people.

    Median target enrolment is 66 among the 55 trials that report a genuine target (sentinel values excluded). 33 of those (60%) plan for fewer than 100 participants.

  4. Menopause research is mostly interventional.

    49 interventional and 6 observational studies make up this index (89.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 14Phase 213Phase 33Phase 49

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 13
Phase 3 3
Phase 4 9

Named interventions

Most-linked intervention names on Menopause records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
11 trials
Placebo Dietary supplement
4 trials
Estradiol Drug
3 trials
MyMenoPlan Other
1 trials
Topical liquid lidocaine Drug
1 trials
Usual Activity Behavioral
1 trials
FP-101 Drug
1 trials
Superficial subcutaneous injection Procedure
1 trials

US sites by state

Facility locations filed on Menopause trials. A trial with sites in several states counts in each.

Colorado 10 trials
California 10 trials
Massachusetts 7 trials
North Carolina 6 trials
Minnesota 5 trials
Illinois 5 trials
Arizona 5 trials
Washington 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Menopause page

55 registered trials, 18 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Menopause condition card totals 55 registered trials; most-linked intervention Placebo; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.